Medicine
Brimonidine 1.5 mg/mL eye drops
Brimonidine 1.5 mg/mL eye drops is a generic prescription medicine for ophthalmic use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 15° to 25°C (59° to 77°F).
Key facts
- Active ingredient (INN)
- Brimonidine
- Brand
- Sold under the generic name
- Strength
- 1.5 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 bottle and 12 more
- Manufacturers
- Alembic PharmaceuticalsIndiaApotexPacific PharmaUpsher-Smith Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 15° to 25°C (59° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D11AX21 Brimonidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 January 2022
- Identifiers
- RxCUI 861208, 861204DailyMed set ID a52b2033-0333-4630-9b1f-e22918b0962c, 64b21e68-610c-5194-ccb2-9d9f6ff8cda9, ee46049d-9f9b-4fb6-b47a-2631971f711c +2NDC 62332-661, 60505-0564, 0832-1420 +2Application ANDA215225, ANDA078479, ANDA216772 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 5 mL in 1 bottle | 46708-661-05 | Alembic PharmaceuticalsIndia | 29 March 2023 |
| 1 bottle in 1 carton / 10 mL in 1 bottle | 46708-661-10 | Alembic PharmaceuticalsIndia | 29 March 2023 |
| 1 bottle in 1 carton / 15 mL in 1 bottle | 46708-661-15 | Alembic PharmaceuticalsIndia | 29 March 2023 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 62332-661-05 | Alembic PharmaceuticalsIndia | 29 March 2023 |
| 1 bottle in 1 carton / 10 mL in 1 bottle | 62332-661-10 | Alembic PharmaceuticalsIndia | 29 March 2023 |
| 1 bottle in 1 carton / 15 mL in 1 bottle | 62332-661-15 | Alembic PharmaceuticalsIndia | 29 March 2023 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 60505-0564-1 | Apotex | 31 January 2022 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 60505-0564-2 | Apotex | 14 March 2022 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 60505-0564-3 | Apotex | 31 January 2022 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 82182-773-05 | Pacific Pharma | 28 February 2022 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 82182-773-10 | Pacific Pharma | 28 February 2022 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 82182-773-15 | Pacific Pharma | 28 February 2022 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 0832-1420-05 | Upsher-Smith Laboratories | 15 November 2025 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 0832-1420-10 | Upsher-Smith Laboratories | 15 November 2025 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 0832-1420-15 | Upsher-Smith Laboratories | 15 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Brimonidine 1.5 mg/mL eye drops.
Other strengths and forms of Brimonidine
Clinical summary
Brimonidine is an alpha-adrenergic agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is available as eye drops, gel and ophthalmic solution for topical use. MedsAcross supplies Brimonidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BrimonidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ALPHAGAN P prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Mirvaso: European public assessment report (EPAR) · European Medicines Agency
Need Brimonidine 1.5 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.